8QLQ
Human MST3 (STK24) kinase in complex with macrocyclic inhibitor JA310
Summary for 8QLQ
| Entry DOI | 10.2210/pdb8qlq/pdb |
| Descriptor | Serine/threonine-protein kinase 24, macrocyclic inhibitor, 1,2-ETHANEDIOL, ... (4 entities in total) |
| Functional Keywords | selective kinase inhibitors, macrocyclic inhibitors, structure-guided drug design, transferase |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 1 |
| Total formula weight | 34959.10 |
| Authors | Balourdas, D.I.,Amrhein, J.A.,Hanke, T.,Knapp, S.,Joerger, A.C.,Structural Genomics Consortium (SGC) (deposition date: 2023-09-20, release date: 2023-11-08, Last modification date: 2024-05-29) |
| Primary citation | Amrhein, J.A.,Berger, L.M.,Balourdas, D.I.,Joerger, A.C.,Menge, A.,Kramer, A.,Frischkorn, J.M.,Berger, B.T.,Elson, L.,Kaiser, A.,Schubert-Zsilavecz, M.,Muller, S.,Knapp, S.,Hanke, T. Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3. J.Med.Chem., 67:674-690, 2024 Cited by PubMed Abstract: MST1, MST2, MST3, MST4, and YSK1 are conserved members of the mammalian sterile 20-like serine/threonine (MST) family that regulate cellular functions such as proliferation and migration. The MST3 isozyme plays a role in regulating cell growth and apoptosis, and its dysregulation has been linked to high-grade tumors. To date, there are no isoform-selective inhibitors that could be used for validating the role of MST3 in tumorigenesis. We designed a series of 3-aminopyrazole-based macrocycles based on the structure of a promiscuous inhibitor. By varying the moieties targeting the solvent-exposed region and optimizing the linker, macrocycle JA310 () was synthesized. JA310 exhibited high cellular potency for MST3 (EC = 106 nM) and excellent kinome-wide selectivity. The crystal structure of the MST3-JA310 complex provided intriguing insights into the binding mode, which is associated with large-scale structural rearrangements. In summary, JA310 demonstrates the utility of macrocyclization for the design of highly selective inhibitors and presents the first chemical probe for MST3. PubMed: 38126712DOI: 10.1021/acs.jmedchem.3c01980 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.64 Å) |
Structure validation
Download full validation report






